Browse by UCL people
Group by: Type | Date
Number of items: 6.
2025
McLean, Jurga;
Chambers, Pinkie;
Steventon, Luke;
Cruickshank, Susanne;
Nabhani-Gebara, Shereen;
(2025)
Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anticancer therapy (SACT).
BMJ Quality & Safety
10.1136/bmjqs-2024-017560.
(In press).
|
|
Mirza, Laaeba;
Steventon, Luke;
Roylance, Rebecca;
Hughes, Chantelle;
Creed, Chiara;
Morris, Emma;
Purcell, Ian;
... Chambers, Pinkie; + view all
(2025)
Regional differences in neo/adjuvant chemotherapy timing in patients with early-stage triple negative breast cancer in England.
Breast Cancer Research and Treatment
, 209
pp. 139-146.
10.1007/s10549-024-07480-x.
|
|
Steventon, Luke;
Nicum, Shibani;
Chambers, Pinkie;
Man, Kenneth;
Dodwell, David;
Wang, Zhe;
Patel, Apini;
... Wei, Li; + view all
(2025)
Risk of secondary myelodysplastic syndromes and acute myeloid leukaemia following poly(ADP-ribose) polymerase inhibitor treatment for advanced-stage recurrent ovarian cancer: a retrospective cohort study in England.
European Journal of Cancer
, Article 115472. 10.1016/j.ejca.2025.115472.
(In press).
|
|
Steventon, Luke;
Nicum, Shibani;
Man, Kenneth;
Dodwell, David;
Wang, Zhe;
Patel, Apini;
Pickwell-Smith, Ben;
... Chambers, Pinkie; + view all
(2025)
Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study.
ESMO Real World Data and Digital Oncology
, 8
, Article 100143. 10.1016/j.esmorw.2025.100143.
|
2024
|
Steventon, Luke;
Nicum, Shibani;
Man, Kenneth;
Chaichana, Ubonphan;
Wei, Li;
Chambers, Pinkie;
(2024)
A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers.
Gynecologic Oncology
, 184
pp. 178-189.
10.1016/j.ygyno.2024.01.052.
|
2023
|
Awan, Sidra;
Bharucha, Pooja;
Steventon, Luke;
Simpson, Helen;
Ahmad, Tanya;
Benafif, Sarah;
Shaw, Heather;
(2023)
Out-of-hours admissions in patients treated with immune checkpoint inhibitors and their primary management with steroids.
Journal of Oncology Pharmacy Practice
(In press).
|
